Public company
Immunovant, Inc.
IMVTCIK 0001764013
Price$30.53
1 year+29.4%
Disclosed transactions60
Buys / sells0 / 30
Max Insider Score42
Connections with evidence12
IMVT · disclosed activity on price
Disclosed transactions
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 25 | Girao TiagoChief Financial Officer | IMVTImmunovant, Inc. Open-market sale | SELL | $188K 6,606 sh | Oct 30, 2026 |
Verified connections
- In industryevidencePharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 4, 2026
- ← Insider ofevidenceGirao TiagoChief Financial Officer · Apr 9, 2026
- ← Insider ofevidenceTorti FrankDirector · Apr 9, 2026
- ← Insider ofevidenceFromkin Andrew J.Director · Apr 9, 2026
- ← Insider ofevidence